Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-13 11:32 am Purchase |
2025-03-31 | 13G | Glacier Bancorp, Inc. GBCI |
Capital Research Global Investors | 6,681,865 5.900% |
6,681,865 (New Position) |
Filing History |
| 2025-05-13 11:32 am Sale |
2025-03-31 | 13G | Insulet Corporation PODD |
Capital Research Global Investors | 6,076,540 8.700% |
-1,695,864 (-21.82%) |
Filing History |
| 2025-05-13 11:32 am Purchase |
2025-03-31 | 13G | Magnite, Inc. MGNI |
Capital Research Global Investors | 12,920,070 9.000% |
5,194,835 (+67.25%) |
Filing History |
| 2025-05-13 11:32 am Sale |
2025-03-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Capital Research Global Investors | 853,746 4.200% |
-143,348 (-14.38%) |
Filing History |
| 2025-05-13 11:32 am Purchase |
2025-03-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX |
Capital Research Global Investors | 14,536,344 5.700% |
14,536,344 (New Position) |
Filing History |
| 2025-05-13 11:32 am Sale |
2025-03-31 | 13G | American International Group, Inc. AIG |
Capital Research Global Investors | 26,063,252 4.400% |
-15,706,923 (-37.60%) |
Filing History |
| 2025-05-13 11:32 am Sale |
2025-03-31 | 13G | CBIZ, Inc. CBZ |
Capital Research Global Investors | 2,707,096 5.000% |
-1,224,879 (-31.15%) |
Filing History |
| 2025-05-13 11:32 am Sale |
2025-03-31 | 13G | Floor & Decor Holdings, Inc. FND |
Capital Research Global Investors | 11,406,314 10.600% |
-1,871,660 (-14.10%) |
Filing History |
| 2025-05-13 11:32 am Purchase |
2025-03-31 | 13G | iRhythm Technologies, Inc. IRTC |
Capital Research Global Investors | 2,202,622 7.000% |
565,596 (+34.55%) |
Filing History |
| 2025-05-13 11:32 am Sale |
2025-03-31 | 13G | Las Vegas Sands Corp. LVS |
Capital Research Global Investors | 27,232,242 3.800% |
-31,592,047 (-53.71%) |
Filing History |
| 2025-05-13 11:32 am Purchase |
2025-03-31 | 13G | Stanley Black & Decker, Inc. SWK |
Capital Research Global Investors | 11,533,527 7.500% |
5,844,408 (+102.73%) |
Filing History |
| 2025-05-13 11:32 am Sale |
2025-03-31 | 13G | TriNet Group, Inc. TNET |
Capital Research Global Investors | 0 0.000% |
-2,822,839 (Position Closed) |
Filing History |
| 2025-04-04 4:24 pm Sale |
2025-03-31 | 13G | TFI International Inc. TFII |
Capital Research Global Investors | 2,154,253 2.600% |
-5,612,709 (-72.26%) |
Filing History |
| 2025-04-04 4:24 pm Sale |
2025-03-31 | 13G | Dayforce Inc DAY |
Capital Research Global Investors | 9,505,799 6.000% |
-8,651,366 (-47.65%) |
Filing History |
| 2025-04-04 4:24 pm Sale |
2025-03-31 | 13G | Haemonetics Corporation HAE |
Capital Research Global Investors | 1,577,323 3.100% |
-2,865,330 (-64.50%) |
Filing History |
| 2025-04-04 4:24 pm Purchase |
2025-03-31 | 13G | BBB Foods Inc. TBBB |
Capital Research Global Investors | 5,357,086 8.600% |
26,872 (+0.50%) |
Filing History |
| 2025-02-13 2:52 pm Purchase |
2024-12-31 | 13G | Silvaco Group, Inc. Common Stock SVCO |
Capital Research Global Investors | 1,442,516 5.100% |
1,442,516 (New Position) |
Filing History |
| 2025-02-13 2:52 pm Purchase |
2024-12-31 | 13G | Byrna Technologies Inc. BYRN |
Capital Research Global Investors | 1,638,421 7.300% |
1,638,421 (New Position) |
Filing History |
| 2025-02-13 2:15 pm Sale |
2024-12-31 | 13G | DTE Energy Company DTE |
Capital Research Global Investors | 18,869,428 9.100% |
-2,063,602 (-9.86%) |
Filing History |
| 2025-02-13 2:15 pm Purchase |
2024-12-31 | 13G | Eastman Chemical Company EMN |
Capital Research Global Investors | 5,886,564 5.100% |
5,886,564 (New Position) |
Filing History |